KAMALI SARVESTANI E, GHADERI A, GHARESI-FARD B. PRODUCTIO N OF PROSTATE-SPECIFIC ANTIGEN (PSA) BY A BREAST CANCER CELL LINE, SK-Br-3. Med J Islam Repub Iran 2002; 16 (1) :41-46
URL:
http://mjiri.iums.ac.ir/article-1-775-en.html
From the Department of Immunology,Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, I.R. Iran. , immunol 2@sums.ac.ir
Abstract: (5382 Views)
PSA is a 33-KDa serine protease that is produced predominantly by prostate
epithelium. However, it has been shown that about 30-40% of female breast tumors
produce PSA and its production is associated with the presence of estrogen
and progesterone receptors. We have now developed a new tissue culture system
to study PSA production in breast cancer and its association with prognostic factors
such as progesterone receptor and c-erbB-2. For this purpose we investigated
the ability of PSA production in five different cell lines, including two breast
cancer cell lines, SK-Br-3 and MDA-MB-453. The PSA in tissue culture supernatant
and cytoplasm of the Sk-Br-3 cell line was detected by western blotting
and immunoperoxidase, respectively. Furthermore, we found lower expression of
c-erbB-2 in Sk-Br-3 than non-PSA producer breast cancer cell line, MDA-MB-
453. Progesterone receptor was expressed by both PSA-positive and -negative
cell lines and only the intensity of staining and the number of positive cells in SkBr-
3 population was higher than MDA-MB-453. According to our findings PSA
can be considered as a good prognostic factor in breast cancer and we suggest that
these two cell lines are a good in vitro model to study the relationship of different
breast cancer prognostic factors and their regulations.
Keywords: PSA, c-erbB-2, Progesterone receptor, Breast cancer, SK-Br-3.